Literature DB >> 17961984

Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.

Cynthia Shannon Weickert1, Debora A Rothmond, Thomas M Hyde, Joel E Kleinman, Richard E Straub.   

Abstract

Genetic and molecular studies indicate that dysbindin-1 plays a role in the pathophysiology of schizophrenia. We examined dysbindin-1 mRNA in the hippocampal formation of patients with schizophrenia and found reduced expression in dentate granule and polymorph cells and in hippocampal field CA3, but not in CA1. Furthermore, there were positive correlations between dysbindin-1 mRNA and expression of synaptic markers known to be reduced in schizophrenia. Our results indicate that previously reported dysbindin-1 protein reductions may be due in part to decreased dysbindin-1 mRNA and that reduced dysbindin-1 may contribute to hippocampal formation synaptic pathology in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961984      PMCID: PMC2246024          DOI: 10.1016/j.schres.2007.05.041

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

Review 1.  Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia.

Authors:  P J Harrison; S L Eastwood
Journal:  Hippocampus       Date:  2001       Impact factor: 3.899

2.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families.

Authors:  Sibylle G Schwab; Michael Knapp; Stephanie Mondabon; Joachim Hallmayer; Margitta Borrmann-Hassenbach; Margot Albus; Bernard Lerer; Marcella Rietschel; Matyas Trixler; Wolfgang Maier; Dieter B Wildenauer
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

3.  Cis-acting variation in the expression of a high proportion of genes in human brain.

Authors:  Nicholas J Bray; Paul R Buckland; Michael J Owen; Michael C O'Donovan
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

Review 4.  Glutamate receptors and transporters in the hippocampus in schizophrenia.

Authors:  Paul J Harrison; Amanda J Law; Sharon L Eastwood
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 5.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

6.  Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.

Authors:  Konrad Talbot; Dan-Sung Cho; Wei-Yi Ong; Matthew A Benson; Li-Ying Han; Hala A Kazi; Joshua Kamins; Chang-Gyu Hahn; Derek J Blake; Steven E Arnold
Journal:  Hum Mol Genet       Date:  2006-09-15       Impact factor: 6.150

7.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.

Authors:  Tadahiro Numakawa; Yuki Yagasaki; Tetsuya Ishimoto; Takeya Okada; Tatsuyo Suzuki; Nakao Iwata; Norio Ozaki; Takahisa Taguchi; Masahiko Tatsumi; Kunitoshi Kamijima; Richard E Straub; Daniel R Weinberger; Hiroshi Kunugi; Ryota Hashimoto
Journal:  Hum Mol Genet       Date:  2004-09-02       Impact factor: 6.150

8.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.

Authors:  Richard E Straub; Yuxin Jiang; Charles J MacLean; Yunlong Ma; Bradley T Webb; Maxim V Myakishev; Carole Harris-Kerr; Brandon Wormley; Hannah Sadek; Bharat Kadambi; Anthony J Cesare; Avi Gibberman; Xu Wang; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Am J Hum Genet       Date:  2002-07-03       Impact factor: 11.025

9.  Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.

Authors:  Cynthia Shannon Weickert; Richard E Straub; Benjamin W McClintock; Mitsuyuki Matsumoto; Ryota Hashimoto; Thomas M Hyde; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Journal:  Arch Gen Psychiatry       Date:  2004-06

10.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more
  68 in total

1.  Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.

Authors:  Erkang Fei; Xiaochuan Ma; Cuiqing Zhu; Ting Xue; Jie Yan; Yuxia Xu; Jiangning Zhou; Guanghui Wang
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

Review 2.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

3.  Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.

Authors:  Katherine H Karlsgodt; Karla Robleto; Heather Trantham-Davidson; Corey Jairl; Tyrone D Cannon; Antonieta Lavin; J David Jentsch
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

Review 4.  Gene expression in the etiology of schizophrenia.

Authors:  Nicholas J Bray
Journal:  Schizophr Bull       Date:  2008-03-11       Impact factor: 9.306

Review 5.  Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders.

Authors:  Katsunori Kobayashi
Journal:  Mol Neurobiol       Date:  2009-01-08       Impact factor: 5.590

6.  The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.

Authors:  Ian J Orozco; Peter Koppensteiner; Ipe Ninan; Ottavio Arancio
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

Review 7.  The dystrobrevin-binding protein 1 gene: features and networks.

Authors:  A Y Guo; J Sun; B P Riley; D L Thiselton; K S Kendler; Z Zhao
Journal:  Mol Psychiatry       Date:  2008-07-29       Impact factor: 15.992

8.  Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression.

Authors:  Tina Tze-Tsang Tang; Feng Yang; Bo-Shiun Chen; Yuan Lu; Yuanyuan Ji; Katherine W Roche; Bai Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

9.  The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.

Authors:  Dion K Dickman; Graeme W Davis
Journal:  Science       Date:  2009-11-20       Impact factor: 47.728

10.  DTNBP1 is associated with imaging phenotypes in schizophrenia.

Authors:  Katherine L Narr; Philip R Szeszko; Todd Lencz; Roger P Woods; Liberty S Hamilton; Owen Phillips; Delbert Robinson; Katherine E Burdick; Pamela DeRosse; Raju Kucherlapati; Paul M Thompson; Arthur W Toga; Anil K Malhotra; Robert M Bilder
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.